Datasets:
timotheeplanes
/
doping

Dataset card Data Studio Files
xet
 Community
1
text
stringlengths
1
17.8k
3.2.2 WADA-accredited laboratories, and other laboratories approved by WADA , are presumed to have conducted Sample analysis and custodial procedures in accordance with the International Standard for Laboratories.
The Athlete or other Person may rebut this presumption by establishing that a departure from the International Standard for Laboratories occurred which could reasonably have caused the Adverse Analytical Finding .
If the Athlete or other Person rebuts the preceding presumption by showing that a departure from the International Standard for Laboratories occurred which could reasonably have caused the Adverse Analytical Finding , then the IOC shall have the burden to establish that such departure did not cause the Adverse Analytical Finding .
3.2.3 Departures from any other applicable International Standard or other anti -doping rule or policy set forth in these Rules shall not invalidate analytical results or other evidence of an anti-doping rule violation, and shall not constitute a defence to an anti-doping rule violation, provided, however, i f the Athlete or other Person establishes that a departure from one of the specific International Standard provisions listed below could reasonably have caused an anti -doping rule violation based on an Advers e Analytical Finding or whereabouts failure , then the IOC shall have the burden to establish that such departure did not cause the Adverse Analytical Finding or whereabouts failure: 3.2.3.1 a departure from the International Standard for Testing and Investigations related to Sample collection or Sample handling which could reasonably have caused an anti -doping rule violation based on an Adverse Analytical Finding , in which case the IOC shall have the burden to establish that such departure did not cause the Adverse Analytical Finding ; 3.2.3.2 a departure from the International Standard for Results Management or International Standard for Testing and Investigations related to Adverse Passport Finding which could reasonably have caused an anti -doping rule violation, in which case the IOC shall have the burden to establish that such departure did not cause the anti -doping rule violation; IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 10 / 49 3.2.3.3 a departure from the International Standard for Results Management related to the requirement to provide notice to the Athlete of the B Sample opening which could reasonably have caused an anti -doping rule violation based on an Adverse Analytical Finding , in which case the IOC shall have the burden to establish that such departure did not cause the Adverse Analytical Finding ; 3.2.3.4 a departure from the International Standard for Results Management related to Athlete notification which could reasonably have caused an anti -doping rule violation based on a whereabouts failure, in which case the IOC shall have the burden to establish that such departure did not cause the whereabouts failure .
3.2.4 The facts established by a decision of a court or professional disciplinary tribunal of competent jurisdiction which is not the subject of a pending appeal shall be irrebuttable evidence against the Athlete or other Person to whom the decision pertained of those facts unless the Athlete or other Person establishes that the decision violated principles of natural justice.
3.2.5 The hearing panel in a hearing on an anti -doping rule violation (including for the avoidance of doubt, the CAS Anti -Doping Division) may draw an inference adverse to the Athlete or other Person who is asserted to have commit ted an anti -doping rule violation based on the Athlete’s or other Person ’s refusal, after a request made in a reasonable time in advance of the hearing, to appear at the hearing (either in person or telephonically as directed by the hearing panel) and to answer questions from the hearing panel and the ITA.
ARTICLE 4 – THE PROHIBITED LIST 4.1 Incorporation of the Prohibited List These Rules incorporate the Prohibited List which is published and revised by WADA as described in Article 4.1 of the Code.
The NOCs shall be responsible for ensuring that their delegations, including their Athletes , are made aware of such Prohibited List.
Notwithstanding the foregoing, ignorance of the Prohibited List shall not constitute an excuse for any Participant or other Person participating in, or accredited to, the Olympic Games Paris 2024 .
4.2 Prohibited Substances and Prohibited Methods Identified on the Prohibited List 4.2.1 Prohibited Substances and Prohibited Methods Unless provided otherwise in the Prohibited List or a revision, the Prohibited List and revisions shall go into effect under these Rules three months after publication by WADA, without requiring any further action by the IOC.
4.2.2 All Athletes and other Persons shall be bound by the Prohibited List, and any revisions thereto, from the date they go into effect, without further formality.
It is the responsibility of all Athletes and other Persons to familiari se themselves with the most up -to-date version of the Prohibited List and all revisions thereto.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 11 / 49 4.2.3 Specified Substances or Specified Methods All Prohibited Substances shall be Specified Substances except as identified on the Prohibited List.
No Prohibited Method shall be a Specified Method unless it is specifically identified as a Specified Method on the Prohibited List.
4.2.4 Substances of Abuse For purposes of applying Article 10 of these Rules , Substances of Abuse shall include those Prohibited Substances which are specifically identified as Substances of Abuse on the Prohibited List because they are frequently abused in society outside of the context of sport.
4.3 WADA ’s Determination of the Prohibited List WADA’s determination of the Prohibited Substances and Prohibited Methods that will be included on the Prohibited List, the classification of substances into categories on the Prohibited List, the classification of a substance as prohibited at all times or In -Competition only, the classification of a substance or method as a Specified Substance , Specified Method or Substance of Abuse is final and shall not be subject to any challenge by an Athlete or other Person , including, but not limited to, any challenge based on an argument that the substance or method was not a masking agent or did not have the potential to enhance performance, represent a health risk or violate the spirit of sport.
4.4 Therapeutic Use Exemptions 4.4.1 The presence of a Prohibited Substance or its Metabolites or Markers , and/or the Use or Attempted Use , Possession or Administration or Attempted Administration of a Prohibited Substance or Prohibited Method shall not be considered an anti -doping rule violation if it is consistent with the provisions of a TUE granted in accordance with the International Standard for Therapeutic Use Exemptions.
4.4.2 The ITA shall appoint the members of the TUEC which shall be composed of specialists in accordance with the International Standard for Therapeutic Use Exemptions .
Each TUE application shall be assessed by three members of the TUEC .
4.4.2.1 The TUEC shall promptly evaluate applications for a TUE and render a decision as quickly as possible, which decision shall be repo rted via ADAMS .
4.4.2.2 The ITA shall promptly notify the Athlete , the Athlete’s NOC, WADA, the relevant Athlete’s National Anti -Doping Organisation and International Federation of the decision of the TUEC .
4.4.2.3 The provisions of the International Standard for Therapeutic Use Exemptions shall be complied with during the entire TUE application, recognition, decision, review and appeal process and applied automatically.
TUEs granted by the TUEC shall be effective for the Olympic Games Paris 2024 only.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 12 / 49 4.4.3 Without prejudice to the review by the TUEC under Article 4.4.
5 below , where the Athlete already has a TUE granted by the Athlete ’s National Anti-Doping Organisation or International Federation and such TUE is available on ADAMS , the Athlete does not need t o apply for the recognition of this TUE which shall be automatically recognised.
4.4.4 Where the Athlete already has a TUE granted by the Athlete ’s National Anti-Doping Organisation or International Federation and provided that such TUE is not available on ADAMS , the Athlete shall submit such TUE to the TUEC for recognition at least 30 days before the start of the Period of the Olympic Games Paris 2024 .
4.4.5 The TUEC shall be entitled, including prior to the Period of the Olympic Games Paris 2024 , to review any TUE in order to ensure that it meets the criteria set out in the International Standard for Therapeutic Use Exemptions and, if necessary, request the provision of further supporting documentation.
If the TUEC decides to review a TUE and determines that it does not meet the aforementioned criteria, and, accordingly, refuse s to recogni se it, it must notify the Athlete , the Athlete’s NOC and the granting Athlete’s National Anti -Doping Organisation or International Federation, and WADA promptly, explaining its reasons .
Such decision shall also be reported via ADAMS .
4.4.6 A decision by the TUEC not to grant or not to recogni se a TUE may be appealed by the Athlete exclusively to WADA .
If the Athlete does not appeal (or WADA decides to uphold the refusal to grant/ recogni se the TUE and so rejects the appeal), the Athlete may not Use the Prohibited Substance or Prohibited Method in question in relation to the Olympic Games Paris 2024 , but any TUE granted by the Athlete ’s National Anti-Doping Organisation or International Federation for that substance or method remains valid outside of the Olympic Games Paris 2024 .
4.4.7 Notwithstanding Article 4.4.
6, WADA may review the TUEC ’s decisions on TUEs at any time, whether upon request by those affected or on its own initiative.
If the TUE decision being reviewed meets the criteria set out in the International Standard for Therapeutic Use Exemptions , WADA will not interfere with it.
If the TUE decision does not meet those criteria, WADA will reverse it.
A decision by WADA to reverse a TUE decision may be appealed by the Athlete , the Athlete’s National Anti -Doping Organization and/or the International Federation affected, exclusively to CAS in accordance with Article 12 of these Rules .
4.4.8 All TUEs must be managed, requested and declared through ADAMS .
All applications, decisions and supporting documentation regarding TUEs must be applied for, managed and notified as soon as possible through ADAMS .
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 13 / 49 ARTICLE 5 – TESTING AND INVESTIGATIONS 5.1 Purpose of Testing and Investigations 5.1.1 Testing and investigations may be undertaken for any anti-doping purposes.
They shall be conducted in conform ity with the provisions of the International Standard for Testing and Investigations and any specific protocols of the IOC and/or the ITA (within the scope of its delegation) supplementing that International Standard , provided that such protocols are compliant with the Code and International Standard for Testing and Investigations .
5.1.2 Testing shall be undertaken to obtain analytical evidence as to whether the Athlete has violated Article 2.1 (P resence of a Prohibited Substance or its Metabolites or Markers in an Athlete’s Sample ) or Article 2.2 ( Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited Method ) of these Rules .
5.2 Authority to Test 5.2.1 In accordance with Article 5.2.3 of the Code, the IOC shall have In-Competition and Out-of-Competition Testing authority over all Athletes in connection with the Olympic Games Paris 2024 .
5.2.2 Accordingly, the ITA may conduct In-Competition and Out-of-Competition Testing on the IOC’s behalf, on any Athlete entered to or who may be entered to participate in the Olympic Games Paris 2024 .
The ITA may notably conduct Out-of-Competition Testing on these Athletes starting from the Period of the Pre -Olympic Games Paris 2024 .
5.2.3 The ITA may require any Athlete over whom the IOC has Testing authority to provide a Sample at any time and at any place.
5.2.4 Subject to Article 5.3 of the Code, the ITA shall have exclusive authority to conduct Testing at the Event Venues during the Period of the Olympic Games Paris 2024 .
In accordance with Article 5.3.1 of the Code , not only the ITA, but also Anti-Doping Organisations with Testing authority over Athletes participating at the Olympic Games Paris 2024 may test such Athletes during the Period of the Olympic Games Paris 2024 outside of the Event Venues.
Such Testing shall be communicated to and coordinated with the I TA.
5.2.5 If an Anti-Doping Organi sation, which would otherwise have Testing authority but is not responsible for initiating and directing Testing at the Olympic Games Paris 2024 , desires to conduct Testing of Athletes at the Event Venues during the Period of the Olympic Games Paris 2024 , the Anti-Doping Organi sation shall first confer with the ITA to obtain permission to conduct and coordinate such Testing .
5.2.6 Notwithstanding the above, WADA shall have In -Competition and Out-of-Competition Testing authority as set out in Article 20.7.
10 of the Code.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 14 / 49 5.3 Delegation of responsibility, overseeing and monitoring of Doping Control 5.3.1 Subject to the International Standard for Code Compliance by Signatories and Article 5.3.2 of these Rules , the IOC has delegate d some of its obligations and responsibilities pursuant to these Rules , including the implementati on of all or part of the Doping Control in relation to the Olympic Games Paris 2024 , including without limitation, test distribution planning, TUEs and Results Management , to the ITA.
The references in these Rules to the ITA shall, where applicable, be construed and interpreted as references to the ITA acting on behalf of the IOC within the scope of the above- mentioned delegation .
The ITA may in turn sub- delegate the responsibility for implementing all or part of the Doping Control in relation to the Olympic Games Paris 2024 to the organising committee for the Olympic Games Paris 2024 (Paris 2024) or any Anti-Doping Organisation or other Delegated Third Parties it deem s to be appropriate (such as a Sample collection agency) .
In such event, Paris 2024 and such Anti-Doping Organisations or Delegated T hird Parties shall act in accordance with these Rules and any further requirements and instructions provided by the ITA .
The delegation of obligations or responsibilities to the ITA shall continue in effect until revocation or withdrawal of such delegation by the IOC at any time and at its own discretion.
In the event of revocation or withdrawal , any references to the ITA in the Rules shall be deemed to be references to the IOC .
5.3.2 Notwithstanding the aforementioned delegation to the ITA or other Delegated Third Parties and, to the extent applicable, any sub- delegation by the ITA as indicated in these Rules , the IOC remains ultimately responsible for Doping Control and for the Code compliance of any Doping Control conducted by the ITA and/or any Anti-Doping Organisation or other Delegated T hird Parties acting under its authority at the Olympic Games Paris 2024 .
5.3.3 Doping Control may be monitored by qualified Person s so authori sed by the ITA and/or the IOC.
5.4 Test Distribution Planning The ITA shall develop , conduct , update and implement an effective test distribution plan for the Olympic Games Paris 2024 complying with the requirements of the International Standard for Testing and Investigations.
The ITA shall be responsible for overseeing the implementation of such test distribution plan and any subsequent changes thereto.
The ITA shall provide the IOC and WADA , promptly upon request, with a copy of such test distribution plan, including any subsequent changes thereto .
5.5 Coordination of Doping Control In order to deliver an effective anti-doping program me for the Olympic Games Paris 2024 and to avoid unnecessary duplication in Doping Control, the ITA, in collaboration with the IOC, Paris 2024 , WADA, the International Federations, other Anti-Doping Organisations and the NOCs shall ensure that there is coordination of Doping Control during both the Period of the Pre-Olympic Games Paris 2024 and the Period of the Olympic Games Paris IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 15 / 49 2024.
The ITA shall also report information about all completed tests, including results, to the members of the Independent Observers Program me.
Where reasonably feasible, Testing shall be coordinated through ADAMS in order to maximi se the effectiveness of the combined Testing effort and to avoid unnecessary repetitive Testing .
All relevant informati on regarding Doping Control and Sample Collection should be promptly entered into ADAMS .
5.6 Athlete Whereabouts Information 5.6.1 Where an Athlete is in a Registered Testing Poo l or other types of T esting pools, the ITA, in collaboration with Paris 2024 , may access the Athlete ’s Whereabouts Filings (as defined in the International Standard for Testing and Investigations) for the period for which the Athlete is subject to the IOC's Testing authority in accordance with Article 5.2 of these Rules .
Such Athletes shall be subject to Consequences for violations of Article 2.4 of these Rules as provided in Article 10.3.2 of the Code.
The IOC and the ITA will access the Athlete's Whereabouts Filings primarily via ADAMS and/or the International Federations or National Anti -Doping Organisation that is receiving the Athlete's Whereabouts Filings.
5.6.2 In addition, each NOC shall provide the ITA with further details with respect to the location and arrival/departure dates of all Athletes belonging to their delegation (including Athletes not forming part of a Registered Testing Poo l or other types of Testing pools) during the Period of the Olympic Games Paris 2024 ; such information shall include, without limitation, the name of the building and room number at which an Athlete is staying at the Olympic Village , detailed accommodation information for Athletes not staying in the Olympic Village, and Athlete ’s training schedules and venues.
Such information shall be provided to the ITA as soon as the NOC becomes aware of Athlete ’s whereabouts information.
For the avoidance of doubt, the ITA may use this information for the purposes of investigations and Doping C ontrols in connection with the Olympic Games Paris 2024 .
The NOCs shall also monitor and manage the whereabouts information and provide any further reasonable assistance requested by the ITA in order to locate Athletes belonging to their delegations during the Period of the Olympic Games Paris 2024 .
Without prejudice to any other Consequences , which, depending on the circumstances, might be applicable if such failure constitutes an anti -doping rule violation pursuant to these Rules , failure to provide the above -mentioned assistance may give rise to measures or sanctions in application of Rule 59.1 and/or Rule 59.2 of the Olympic Charter.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 16 / 49 5.6.3 Upon request by the ITA, Athletes and the NOC shall directly provide to the ITA (or make available to the I TA) information regarding Athletes’ location during the Period of the Olympic Games Paris 2024 (information as mentioned above under Article 5.6.2), in the manner requested by the ITA.
Athletes shall respect any time -limit impose d by the ITA for the provision of such information.
Without prejudice to any other Consequences , which, depending on the circumstances, might be applicable if such failure constitutes an anti -doping rule violation pursuant to these Rules , failure to provide the above -mentioned information may give rise to measures or sanctions in application of Rule 59.2 of the Olympic Charter.
5.7 Investigations and Intelligence Gathering The ITA and the IOC shall have the capability to conduct, and shall conduct, investigations and gather intelligence as required by the International Standard for Testing and Investigations and the International Standard for Results Management .
5.8 Independent Observer Program me The IOC shall authori se and, in collaboration with the ITA and Paris 2024 , facilitate the Independent Observer Program me at the Olympic Games Paris 2024 .
ARTICLE 6 – ANALYSIS OF SAMPLES Samples shall be analysed in accordance with the following principles: 6.1 Use of Accredited Laboratories , Approved Laboratories and Other Laboratories In accordance with the Code and for purposes of directly establishing an Adverse Analytical Finding under Article 2.1 of these Rule s, Samples shall be analysed only in laboratories (or satellite facilities) accredited or otherwise approved by WADA .
As provided in Article 3.2 of these Rules , anti-doping rule violations may be established by any reliable means.
This would include, for example, reliable laboratory or other forensic testing conducted outside of WADA -accredited or approved laboratories.
6.2 Purpose of Analysis of Samples and Data Samples and related analytical data or Doping Control information shall be analysed to detect Prohibited Substances and Prohibited Methods and other substances as may be directed by WADA pursuant to the Monitoring Program me described in Article 4.5 of the Code; or to assist in profiling relevant parameters in an Athlete ’s urine, blood or other matrix, including for DNA or genomic profiling; or for any other legitimate anti -doping purpose.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 17 / 49 6.3 Research on Samples and Data Samples, related analytical data and Doping Control information may be used for anti -doping research purposes, although no Sample may be used for research without the Athlete's written consent.
Samples and related analytical data or Doping Control information used for research purposes shall first be processed in such a manner as to prevent Samples and related analytical data or Doping Control information being traced back to a particular Athlete .
Any research involving Samples and re lated analytical data or Doping Control information shall adhere to the principles set out in Article 19 of the Code .
6.4 Standards for Sample Analysis and Reporting 6.4.1 Laboratories shall analyse Samples and report results in conformity with the International Standard for Laboratories.
6.4.2 Laboratories at their own initiative and expense may analyse Samples for Prohibited Substances or Prohibited Methods not included on the standard Sample analysis menu, or as requested by the ITA.
Results from any such analysis shall be reported to the ITA and have the same validity and Consequence s as any other analytical result.
6.5 Further Analysis of a Sample Prior to or During Results Management There shall be no limitation on the authority of a laboratory to conduct repeat or additional analysis on a Sample prior to the time the ITA notifies an Athlete that the Sample is the basis for an Article 2.1 anti -doping rule violation charge .
If after such notification the ITA wishes to conduct additional analysis on that Sample , it may do so with the consent of the Athlete or approval from a hearing body .
6.6 Further Analysis of a Sample After it has been Reported as Negative or has Otherwise not Resulted in an Anti -Doping Rule Violation Charge After a laboratory has reported a Sample as negative, or the Sample has not otherwise resulted in an anti -doping rule violation charge, it may be stored and may be subject to further analyses at any time for the purpose of Article 6.2 of these Rules by the IOC, the ITA or WADA .
Any other Anti-Doping Organi sation with authority to test the Athlete that wishes to conduct further analysis on a stored Sample may do so with the permission of the IOC or WADA , and shall be responsible for any follow- up Results Management .
Such further analysis of Samples shall conform with the requirements of the International Standard for Laboratories applicable at the time of the further analysis .
6.7 Split of A or B Sample Where the IOC, the ITA, WADA and/or a WADA -accredited laboratory (with approval from the IOC, the ITA or WADA ) wishes to split an A or B Sample for the purpose of using the first part of the split Sample for an A Sample analysis and the second part of the split Sample for confirmation, then the procedures set forth in the International Standard for Laboratories shall be followed.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 18 / 49 6.8 WADA ’s Right to Take P ossession of Samples and Data WADA may, in its sole discretion at any time, with or without prior notice, take physical possession of any Sample and related analytical data or information in the possession of a laboratory or the ITA.
Upon request by WADA , the laboratory or the ITA in posse ssion of the Sample or data shall immediately grant access to and enable WADA to take physical possession of the Sample or data.
If WADA has not provided prior notice to the laboratory or the ITA before taking possession of a Sample or data, it shall provide such notice to the laboratory and to the ITA whose Samples or data have been taken by WADA within a reasonable time after taking possession.
After analysis and any investigation of a seized Sample or data, WADA may direct another Anti -Doping Organi sation with authority to test the Athlete to assume Results Management responsibility for the Sample or data if a potential anti -doping rule violation is discovered.
ARTICLE 7 – RESULTS MANAGEMENT , RESPONSIBILITY, INITIAL REVIEW, NOTICE AND PROVISIONAL SUSPENSIONS Results Management under the Code and these Rules (as set forth in Articles 7, 8 and 1 2) establishes a process designed to resolve anti-doping rule violations matters in a fair, expeditious and efficient manner.